Noah Auerhahn

https://wefunder.com/noah.auerhahn

Follower count: 16

CEO, Uncommon Therapeutics (YC W25), Developed a polytherapy to dramatically increase the quality of life for people with Rhett syndrome.

Recent investments

Related profile links